Karolinska Development (STO:KDEV) has stopped investing in three of its portfolio biotechs and fully written off its outlay in the businesses to date. The decisions contributed to the valuation of the ...

Karolinska Development (STO:KDEV) has slashed the value of its portfolio after adopting a new way of tallying up what its early-stage biotech investments are worth. The new accounting model and the ...

If the original Linux-based FoxBox SMS didn't boast quite the capabilities you were looking for, then perhaps KDev's upgraded FoxBox MMS will be more to your liking. Like the original FoxBox, it'll ...

Karolinska Development AB ( (SE:KDEV)) just unveiled an update. Karolinska Development AB’s portfolio company, Umecrine Cognition, has published promising data on the benefits of early treatment with ...

Tune into live earnings calls Now streaming directly on quote pages.

STOCKHOLM, SWEDEN – August 20, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its Chairman of the Board, Professor Hans Wigzell, has informed the Board that he resigns ...

As of 4:50:23 pm GMT+1. Market open.

Karolinska Development AB ( (SE:KDEV)) has issued an announcement. Karolinska Development’s portfolio company, SVF Vaccines, has presented promising preclinical data on its immunotherapy, SVF-001, ...

Karolinska Development [KDEV], developer of life science innovations that meet tomorrow's medical need, will visit the NASDAQ MarketSite in Times Square. In honor of the occasion, Torbjörn Bjerke, CEO ...

New firm will include existing portfolio company Akinion and four to five new project businesses. Swedish life science investor and incubator organization Karolinska Development has established a new ...